These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29741399)

  • 1. Enzalutamide and analytical interferences in digoxin assays.
    Deguigne M; Brunet M; Abbara C; Turcant A; Le Roux G; Lelièvre B
    Clin Toxicol (Phila); 2018 Nov; 56(11):1150-1154. PubMed ID: 29741399
    [No Abstract]   [Full Text] [Related]  

  • 2. First-time prescription of enzalutamide in a patient treated with fluindione and digoxin: serial drug interactions.
    Strobbe G; Pannier D; Villain A; Feutry F; Marliot G
    Acta Oncol; 2019 Aug; 58(8):1167-1169. PubMed ID: 31032691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparability of a new turbidimetric digoxin test with other immunochemical tests and with HPLC--a multicenter evaluation.
    Scholer A; Boecker J; Engelmayer U; Feldmann K; Hannak D; Kattermann R; Oellerich M; Raith H; Schlebusch H; Wieland H; Willems D; Jarausch J; Domke I
    Clin Chem; 1997 Jan; 43(1):92-9. PubMed ID: 8990228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids.
    Steimer W; Müller C; Eber B
    Clin Chem; 2002 Mar; 48(3):507-16. PubMed ID: 11861441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Falsely Elevated Digoxin Levels in Patients on Enzalutamide.
    Kalra D; Tesfazghi M
    Circ Heart Fail; 2020 Jul; 13(7):e007008. PubMed ID: 32527146
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of possible interference by digoxin-like immunoreactive substances on the Architect iDigoxin CMIA in serum samples from pregnant women, and patients with liver disease, renal insufficiency, critical illness, and kidney and liver transplant.
    Lampon N; Pampin F; Tutor JC
    Clin Lab; 2012; 58(11-12):1301-4. PubMed ID: 23289202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical repercussions of analytical interferences due to aldosterone antagonists in digoxin immunoassays: an assessment.
    Cobo A; Martín-Suarez A; Calvo MV; Domínguez-Gil A; de Gatta MM
    Ther Drug Monit; 2010 Apr; 32(2):169-76. PubMed ID: 20216123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a high-performance liquid chromatography method for quantification of carbamazepine with chemiluminescent microparticle immunoassay.
    Guerrero Garduño Ó; González-Esquivel DF; Escalante-Membrillo C; Fernández Á; Rojas-Tomé IS; Jung Cook H; Castro N
    Biomed Chromatogr; 2016 Jun; 30(6):933-7. PubMed ID: 26433002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
    DeVore KJ; Hobbs RA
    Pharmacotherapy; 2007 Mar; 27(3):472-5. PubMed ID: 17316159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abbott ARCHITECT clinical chemistry and immunoassay systems: digoxin assays are free of interferences from spironolactone, potassium canrenoate, and their common metabolite canrenone.
    DeFrance A; Armbruster D; Petty D; Cooper KC; Dasgupta A
    Ther Drug Monit; 2011 Feb; 33(1):128-31. PubMed ID: 21079546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin-induced digoxin toxicity.
    Morton MR; Cooper JW
    DICP; 1989 Sep; 23(9):668-70. PubMed ID: 2800579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new interference in some digoxin assays: anti-murine heterophilic antibodies.
    Liendo C; Ghali JK; Graves SW
    Clin Pharmacol Ther; 1996 Nov; 60(5):593-8. PubMed ID: 8941034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of Asian, American, and Indian (Ashwagandha) ginsengs in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay.
    Dasgupta A; Kang E; Olsen M; Actor JK; Datta P
    Arch Pathol Lab Med; 2007 Apr; 131(4):619-21. PubMed ID: 17425395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Chinese medicines Chan Su and Lu-Shen-Wan on serum digoxin measurement by Digoxin III, a new digoxin immunoassay.
    Reyes MA; Actor JK; Risin SA; Dasgupta A
    Ther Drug Monit; 2008 Feb; 30(1):95-9. PubMed ID: 18223469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs.
    Dasgupta A; Wu S; Actor J; Olsen M; Wells A; Datta P
    Am J Clin Pathol; 2003 Feb; 119(2):298-303. PubMed ID: 12580002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical performance of a monoclonal digoxin assay by dry chemistry on the Vitros 950.
    Frezzotti A; Giordano G; Margarucci Gambini AM
    Scand J Clin Lab Invest; 1999 Oct; 59(6):431-7. PubMed ID: 10612554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin immunoassays on the ARCHITECT i2000SR and ARCHITECT c8000 analyzers are free from interferences of Asian, Siberian, and American ginseng.
    Baugher BW; Berman M; Dierksen JE; Armbruster DA; Dasgupta A
    J Clin Lab Anal; 2015 Jan; 29(1):1-4. PubMed ID: 24659366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A suspected case of falsely low digoxin and vancomycin concentrations caused by free kappa light chains with PETINIA method.
    Tang NY; Walewski K; Carey-Ballough R; Sykes E; Sun Q
    Pract Lab Med; 2022 May; 30():e00277. PubMed ID: 35541501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly patients with suspected chronic digoxin toxicity: A comparison of clinical characteristics of patients receiving and not receiving digoxin-Fab.
    Arbabian H; Lee HM; Graudins A
    Emerg Med Australas; 2018 Apr; 30(2):242-248. PubMed ID: 29316267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.